Emerging studies suggest this peptide, a dual stimulator targeting both GLP-1 and GIP , could represent a significant step forward for body management . Preliminary patient trials have shown substantial reductions in body fat , possibly exceeding other obesity therapies . Nevertheless , further assessment is necessary to completely assess its lo… Read More